 efficacy Navajo infants conjugate vaccine consisting Haemophilus influenzae type polysaccharide Neisseria outer-membrane protein complex BACKGROUND AND METHODS Several conjugate vaccines Haemophilus influenzae type search protection young infants safety efficacy conjugate vaccine influenzae type capsular polysaccharide outer-membrane protein complex OMPC Neisseria meningitidis serogroup double-blind placebo trial Navajo infants high risk systemic infections influenzae type infants first dose vaccine placebo days age second days age RESULTS infants trial vaccine placebo mean follow-up days vaccine group days placebo group age months systemic influenzae type infection vaccine group placebo group point estimate efficacy percent percent confidence interval percent influenzae type infections placebo group children doses influenzae type infection vaccine group placebo group point estimate efficacy percent percent confidence interval percent single infection vaccine group months age infant osteomyelitis first second doses influenzae type infections vaccine group placebo group point estimate efficacy percent percent confidence interval percent CONCLUSIONS influenzae type OMPC vaccine months age safe high rate protection invasive disease influenzae type infants age months Protection first dose